Pathogenic Mutations Associated with
Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to
the Ras Inactivator Neurofibromin
Führer, S., Tollinger, M., Dunzendorfer-Matt, T. (2019) J. Mol.
Biol. 431, 3889-3899
Crystal structure of the
human lysosomal mTORC1 scaffold complex and its impact on signaling
de Araujo, M.E.G., Naschberger, A., Fürnrohr, B.G., Stasyk, T.,
Dunzendorfer-Matt, T., Lechner, S., Welti, S., Kremser, L., Shivalingaiah, G.,
Offterdinger, M., Lindner, H.H., Huber, L.A., Scheffzek K. (2017) Science. 358: 6361, 377-381
LAMTOR/Ragulator is a negative regulator
of Arl8b- and BORC-dependent late endosomal positioning
Filipek P.A., de Araujo M.E.G., Vogel G.F., De Smet C.H., Eberharter D.,
Rebsamen M., Rudashevskaya E.L., Kremser L., Yordanov T., Tschaikner P.,
Fürnrohr B.G., Lechner S., Dunzendorfer-Matt T., Scheffzek K., Bennett K.L.,
Superti-Furga G., Lindner H.H., Stasyk T., Huber L.A. (2017) J Cell Biol.
The
neurofibromin recruitment factor Spred1 binds to the GAP related domain without
affecting Ras inactivation
Dunzendorfer-Matt, T.*, Mercado, E.*, Maly, K., McCormick, F., Scheffzek, K.
(2016) Proc. Natl Acad Sci USA 113,
7497-7502
Transcriptional control
of DNA replication licensing by Myc
Valovka, T., Schönfeld, M.,
Raffeiner, P., Breuker, K., Dunzendorfer-Matt, T., Hartl, M., Bister, K. (2013)
Sci. Rep. 3: 3444, 1-9
Solution structure of
the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53
Kostic, M., Matt, T.,
Martinez-Yamout, M.A., Dyson, H.J., Wright, P.E. (2006) J. Mol.
Biol. 363, 433-450
The CBP/p300 TAZ1 domain in its native state is not a binding partner
of MDM2
Matt, T., Martinez-Yamout M.A., Dyson,
H.J., Wright, P.E. (2004) Biochem. J.
381, 685-691
(Commentary: Biochem. J. 381, e3-e4, 2004; Faculty of 1000 “Must Read” paper, August
2004)
Cell transformation by
the v-myc oncogene abrogates c-Myc/Max-mediated suppression of a C/EBP
beta-dependent lipocalin gene
Hartl, M.*, Matt, T.*, Schüler, W.,
Siemeister, G., Kontaxis, G., Kloiber, K., Konrat, R., Bister, K. (2003) J. Mol. Biol. 333, 33-46
Structure, function, and
dynamics of the dimerization and DNA-binding domain of oncogenic transcription
factor v‑Myc
Fieber, W., Schneider, M.L., Matt, T.,
Kräutler, B., Konrat, R., Bister, K. (2001) J. Mol. Biol.
307, 1395-1410
* shared first authorship
Molekulare Regulatoren in der
Tumorentstehung
Bister, K., Matt, T., Hartl, M. (2005) BIOforum 1-2, S. 36–37
The LIM domain protein CRP2 interacts with EB1, a
binding partner of the human tumor suppressor APC
Matt, T., Dowler, E., Pircher, H., Hartl, M., Schanda, P., Kontaxis, G.,
Bister, K., Konrat, R. 13th AEK/AIO Cancer Congress, Mar 13-16,
2005, Würzburg, Germany Abstract in
(2005) Onkologie 28, S2 25
1. Österreichisches
Neurofibromatosesymposium und Österreichische Patiententagung für
Neurofibromatose (2017) Wien
NF conference (2016) Austin, USA
Onkologisches Kolloquium der Österr. Krebshilfe Tirol (2014) Innsbruck
Life Science Meeting (2014) Innsbruck
Workshop der deutschen
Arbeitsgemeinschaft für Neurofibromatosen (2013) München
ÖGMBT meeting (2013) Innsbruck
BIOSTRUCT@INNSBRUCK (2013) Innsbruck
NF conference (2013) Monterey, CA, (poster, prize awarded)
Tiroler
Gipfelsieg: SCIENCE 2017
Neue Einblicke in die Neurofibromatose Typ1
(NF1) 2016
Biostruct@Innsbruck 2013 & ipoint Mar 2013